SMOKING CESSATION
Tobacco use is the most common preventable cause of death. About half of the people who don't quit smoking will die of smoking-related problems. Quitting smoking is important for your health and provides many benefits.
Quitting is not easy. There are many ways to quit smoking. Some people stop "cold turkey." Others benefit from counseling, medicines, or products that help reduce nicotine addiction. Wellbutrin, Chantix, and the Nicotine Patch are some medicines that are used to help people quit.
Quitting is not easy. There are many ways to quit smoking. Some people stop "cold turkey." Others benefit from counseling, medicines, or products that help reduce nicotine addiction. Wellbutrin, Chantix, and the Nicotine Patch are some medicines that are used to help people quit.
Sponsored by Pfizer
Who?: The researchers at Princeton Medical Institute are seeking male or female cigarette smokers, 18-75 years, smoked an average of at least 10 cigarettes per day during past year and during the month prior to the screening visit, motivated to stop smoking and considered suitable for a smoking cessation attempt. Other criteria for eligibility will be discussed with interested persons, without obligation, when calling the telephone number listed below.
What?: The purpose of this clinical research study is to examine important safety aspects (such as agitation, aggression and depression) of the Investigational drugs compared to placebo (“dummy pills” that do not contain any medicine) and nicotine-replacement therapy (“the patch”) in smokers with or without a history of being diagnosed with a psychiatric disorder. This study will also examine how well Investigational drugs will work to help people with and without psychiatric disorders quit smoking
When?: Up to 7 months
Compensation?: Compensation may be available for time and travel.
Chance for Placebo?: 1 out of 4 (25% Chance)
What?: The purpose of this clinical research study is to examine important safety aspects (such as agitation, aggression and depression) of the Investigational drugs compared to placebo (“dummy pills” that do not contain any medicine) and nicotine-replacement therapy (“the patch”) in smokers with or without a history of being diagnosed with a psychiatric disorder. This study will also examine how well Investigational drugs will work to help people with and without psychiatric disorders quit smoking
When?: Up to 7 months
Compensation?: Compensation may be available for time and travel.
Chance for Placebo?: 1 out of 4 (25% Chance)